$6.77 0.17 (+2.58%)
11/6/2009 4:00 PM

Nanosphere (NSPH)

CAPS Rating: 3 out of 5

Current Price $6.77 Mkt Cap $150.5M
Open $6.50 P/E Ratio 0.10
Prev. Close $6.60 Div. (Yield) N/A (N/A)
Daily Range $6.50 - $6.91 Volume 64,355
52-Wk Range $2.71 - $8.61 Avg. Daily Vol. 116,000

NSPH News and Commentary

Related News and Articles

Caps

How do you think NSPH will perform vs the S&P 500?

Add Stock to Watchlist

All Members

79 Outperform
11 Underperform
 

All-Star Members

23 Outperform
4 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top NSPH Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

therailsplitter (99.27)
Submitted April 03, 2009

I do TNT testing where I work and if approved by the FDA this assay will mean serious $$$ for this company seeing as it is an extremely important test indicating the occurrence of several different heart disorders, including myocardial infarction.… More

RAFAELTOSCANO (< 20)
Submitted March 27, 2008

these kind of companies usually tend to work better on a long the range as it takes time to develope new items.

NSPH VS S&P 500 (SPY)

Fools bullish on NSPH are also bullish on:

Fools bearish on NSPH are also bearish on:

Recent Community Commentary

Read the most recent pitches from members about NSPH.

Recs

0
Member Avatar TMFER (94.25) Submitted: 10/8/2009 9:39:23 AM : Outperform Start Price: $4.44 NSPH Score: +36.87

Picked this on a whim.... looks like it's doing alright :)

Recs

0
Member Avatar fojaha (63.81) Submitted: 6/7/2009 7:04:30 PM : Outperform Start Price: $5.01 NSPH Score: +19.78

Baught in when this co. wasnt ratable in caps. Im going to ride it for a little longer and get out. Im concerned about tresuries. dont wish to hang on to long. Right now i dont want stocks long term unles they pay div excepting commodities.

Recs

1
Member Avatar therailsplitter (99.27) Submitted: 4/3/2009 2:30:50 PM : Outperform Start Price: $4.74 NSPH Score: +13.70

I do TNT testing where I work and if approved by the FDA this assay will mean serious $$$ for this company seeing as it is an extremely important test indicating the occurrence of several different heart disorders, including myocardial infarction. Thus, this is an extremely critical test and must be completed ASAP.

I'd call this a speculative buy at this point with great potential and a tremendous growth opportunity. If the FDA approves the next 4 tests in their pipeline this company will be a definite buy.

Note: Healthcare is virtually untouchable no matter what the state of the economy, especially diagnostics which hospitals cannot live without.

Disclosure: I am also putting my money where my mouth is as I own this in my real portfolio with my sight on the long-long-term.

Leaderboard

Find the members with the highest scoring picks in NSPH.

Score Leader

matteo32

matteo32 (76.25) Score: +47.63

VIVA LA VITA !!!!!!!!!!!!!!!!!!! VIVA L' ITALIA !!!!!!

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score Commentary
TMFER 94.25 7/16/2009 Outperform 5Y $4.44 +52.47% +15.60% +36.87 1 Comment
withoutlimits 89.90 1/15/2008 Underperform 1Y $14.06 -51.85% -20.14% +31.71
Docb4fun 65.51 3/24/2009 Outperform 1Y $4.26 +58.92% +33.24% +25.68
DUCKBUCK 69.19 12/29/2008 1/23/2009 Outperform 3M $4.45 +52.13% +26.83% +25.30
jbc842 < 20 5/6/2008 Outperform 5Y $6.64 +1.96% -20.70% +22.66
DCMonty25 78.97 5/1/2008 Outperform 5Y $6.77 0% -20.70% +20.70 1 Comment
renolayton 97.23 12/7/2007 Underperform 1Y $12.48 -45.75% -25.88% +19.88
fojaha 63.81 6/8/2009 Outperform 3M $5.01 +35.13% +15.35% +19.78 1 Comment
kcfighter 44.81 6/29/2009 Outperform 5Y $4.99 +35.67% +16.86% +18.81
hurocy1198 < 20 4/25/2008 Outperform NS $6.88 -1.60% -20.33% +18.73

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRonBaron < 20 3/31/2008 Outperform NS $8.66 -21.82% -15.82% -6.01 1 Comment
TrackLeerinkSwan 84.26 12/11/2007 Outperform NS $13.90 -51.29% -26.06% -25.23
TrackFoxPitt 30.67 12/11/2007 Outperform NS $13.90 -51.29% -26.06% -25.23
TrackPiperJaff 80.38 12/11/2007 Outperform NS $14.75 -54.10% -26.23% -27.87
TrackCreditSuiss 91.16 12/11/2007 Outperform NS $14.70 -53.95% -26.16% -27.79

Featured Broker Partners